Related Experiment Video

Updated: Jun 5, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Development of blood glucose control for extremely premature infants

Aaron J Le Compte1, J Geoffrey Chase, Adrienne Lynn

  • 1Department of Mechanical Engineering, University of Canterbury, New Zealand.

Computer Methods and Programs in Biomedicine
|January 21, 2011
PubMed

Insights

A new model-based controller helps manage blood glucose (BG) in extremely premature neonates using insulin therapy. This approach adapts to individual metabolic states, showing promise for improved neonatal care and outcomes.

Area of Science:

  • Neonatal Medicine
  • Biomedical Engineering
  • Control Systems

Background:

  • Hyperglycemia in extremely premature neonates is associated with increased mortality and adverse outcomes.
  • Insulin therapy is crucial for managing blood glucose levels and supporting growth in this vulnerable population.

Purpose of the Study:

  • To develop and evaluate a model-based stochastic targeted controller for adaptive insulin infusion in extremely premature neonates.
  • To assess the controller's ability to adapt to individual metabolic states and clinical practice variations.

Main Methods:

  • Development of a model-based stochastic targeted controller for adaptive insulin infusion.
  • Simulation studies using a virtual patient cohort (n=25) to evaluate targeting common blood glucose ranges.
  • Assessment of controller sensitivity to missed glucose measurements and delayed interventions.
  • Initial clinical pilot trials to compare simulation and real-world performance.

Main Results:

  • Simulations demonstrated the controller's ability to target various blood glucose ranges.
  • The controller showed robustness to simulated errors like missed measurements and delayed interventions.
  • Initial clinical pilot trials confirmed that the model's performance aligned with simulation expectations.

Conclusions:

  • Model-based stochastic targeted glucose control, validated through patient-specific virtual trials, offers effective protocols for extremely premature neonates.
  • Long-term trials indicate fundamental success, but clinical interface design is critical for ensuring compliance and optimal control.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...